CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $78,588,440
- in 8 filings, $78.6M under 10b5-1 plans
Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
- Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
- Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
- Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
- Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-10-09 | Patel Sanj K Chairman & CEO | Sale | −670 | $21.00 | $14K | 211,900 |
| 2020-10-09 | Patel Sanj K Chairman & CEO | Option exercise · Share Option | −872 | 502,896 | ||
| 2020-09-10 | Patel Sanj K Chairman & CEO | Grant or award · Share Option | +180,000 | 180,000 | ||
| 2020-09-10 | Beetham Thomas W. EVP & Chief Legal Officer | Grant or award · Share Option | +75,000 | 75,000 | ||
| 2020-09-10 | Paolini John F. SVP & Chief Medical Officer | Grant or award · Share Option | +50,000 | 50,000 | ||
| 2020-09-10 | Rizvi Qasim Chief Commercial Officer | Grant or award · Share Option | +75,000 | 75,000 | ||
| 2020-06-30 | Megna Michael R Chief Accounting Officer | Grant or award | +641 | $9.51 | $6K | 1,778 |
Page 74 of 74 · 1,467 trades